.Viridian Rehabs' period 3 thyroid eye ailment (TED) scientific test has attacked its own primary an...
.Along with a powerful performance history for determining rough diamonds, Bain Financing Lifespan S...
.The recent decision to merge Genentech's 2 cancer teams was made for "medical factors," execs clari...
.Terns Pharmaceuticals' choice to drop its liver condition passions might however pay, after the bio...
.Merck & Co.'s long-running effort to land a hit on little cell bronchi cancer cells (SCLC) has a...
.Some patients with non-small cell lung cancer (NSCLC) have anomalies in a gene referred to as indiv...
.MBX has fleshed out plannings to take in over $136 million from its own IPO as the biotech seeks to...
.Relay Rehabs has actually beaten its survival target in a first-in-human bosom cancer cells researc...
.AstraZeneca has used artificial intelligence to design a special biomarker for its Daiichi Sankyo-p...
.AstraZeneca executives claim they are "certainly not anxious" that the failing of tozorakimab in a ...